Incident reporting and patient safety

Reporting is useful, but more emphasis is needed on measurement and safety improvement programmes

• Publication year

  2007

• Venue

  British medical journal

• Publication date

  2007-01-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.39049.545880.BEPMID 17218668PMCID PMC1767297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.

  2009cited by this paper
• Sugammadex Review of its Use in Anaesthetic Practice

  2009cited by this paper
• WITHDRAWN: Interventions for preventing falls in elderly people.

  2009cited by this paper
• Surveillance for foodborne disease outbreaks - United States, 2006.

  2009cited by this paper
• The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK

  2009cited by this paper
• Rapidly destructive osteoarthritis of the hip joint: a case series

  2008cited by this paper
• Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent

  2008cited by this paper
• Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care Unit

  2008cited by this paper
• Reversal of Profound Rocuronium-induced Blockade with Sugammadex: A Randomized Comparison with Neostigmine

  2008cited by this paper
• Nerve growth factor as an angiogenic factor.

  2008cited by this paper
• Rapid destruction of the hip joint in osteoarthritis

  2008cited by this paper
• Osteonecrosis of the femoral head: Part 1—Aetiology, pathogenesis, investigation, classification

  2007cited by this paper
• Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate.

  2007cited by this paper
• Avascular necrosis of the femoral head: vascular hypotheses.

  2006cited by this paper
• Protecting the health of the public--Institute of Medicine recommendations on drug safety.

  2006cited by this paper
• The costs of fatal and non-fatal falls among older adults

  2006cited by this paper
• Sex workers to pay the price

  2006cited by this paper
• Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses

  2006cited by this paper
• Diagnosis and treatment of chronic hepatitis C infection

  2006cited by this paper
• Variation in Hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom

  2006cited by this paper
• Aberrant crypt foci.

  2006cited by this paper
• Clinical pathways for patients with newly diagnosed hepatitis C – What actually happens

  2006cited by this paper
• Paying the price: health care and prostitution.

  2006cited by this paper
• Sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review

  2006cited by this paper
• A proposal for radical changes in the drug-approval process.

  2006cited by this paper
• Missed contraceptive pill recommendations.

  2005cited by this paper
• Implementing and Validating a Comprehensive Unit-Based Safety Program

  2005cited by this paper
• Prevention of falls and consequent injuries in elderly people.

  2005cited by this paper
• Prioritizing punitive responses over public health: commentary on the Home Office consultation document Paying the Price

  2005cited by this paper
• The many faces of sex work

  2005cited by this paper
• Prostitutes are people too.

  2005cited by this paper
• Development of the ICU Safety Reporting System

  2005cited by this paper
• Sex work and the law.

  2005cited by this paper
• Sex-work harm reduction.

  2005cited by this paper
• A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.

  2005influential reference
• Prostitutes are people too.

  2005cited by this paper
• Fall Prevention in Residential Care: A Cluster, Randomized, Controlled Trial

  2004influential reference
• Analysis of clinical incidents: a window on the system not a search for root causes

  2004cited by this paper
• Regulatory expectations during product development for tumour vaccines.

  2004cited by this paper
• Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health's educational campaign.

  2004cited by this paper
• Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

  2004cited by this paper
• Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials

  2004cited by this paper
• Prostitution laws: health risks and hypocrisy

  2004cited by this paper
• Improving safety with information technology.

  2003cited by this paper
• Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial

  2003cited by this paper
• A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

  2002influential reference
• Pathogenesis and natural history of osteonecrosis.

  2002cited by this paper
• Rapidly destructive osteoarthritis of the hip: MR imaging findings.

  2002cited by this paper
• Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States)

  2002cited by this paper
• Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

  2002cited by this paper
• Use of Prescription Weight Loss Pills among U.S. Adults in 19961998

  2001cited by this paper
• Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

  2001cited by this paper
• Guideline for the Prevention of Falls in Older Persons

  2001cited by this paper
• Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials.

  2000cited by this paper
• Phenotypic Knockout of Nerve Growth Factor in Adult Transgenic Mice Reveals Severe Deficits in Basal Forebrain Cholinergic Neurons, Cell Death in the Spleen, and Skeletal Muscle Dystrophy

  2000cited by this paper
• Quality of life related to fear of falling and hip fracture in older women: a time trade off study.

  2000cited by this paper
• High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.

  1999cited by this paper
• An evaluation of adverse incident reporting.

  1999cited by this paper
• The FDA and drug safety.

  1998cited by this paper
• Aberrant crypt foci of the colon as precursors of adenoma and cancer

  1998cited by this paper
• Dietary sucrose and starch affect dysplastic characteristics in carcinogen-induced aberrant crypt foci in rat colon.

  1997cited by this paper
• Feminism and the state in later Victorian England

  1995cited by this paper
• Prostitution: would legalisation help?

  1993cited by this paper
• Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features.

  1992cited by this paper
• Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate.

  1992cited by this paper
• Rapidly progressive osteoarthritis of the hip.

  1987cited by this paper
• Osteoarthritis I: epidemiology.

  1984influential reference
• Nerve growth factor.

  1975cited by this paper
• Collected Works of John Stuart Mill

  1974cited by this paper
• NEUROMUSCULAR BLOCKING AGENTS

  1961cited by this paper
• Crime and sin.

  1960cited by this paper
• Crime and Sin

  1960cited by this paper

• Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer

  2026cites this paper
• Increasing Diversity in Head and Neck Cancer Clinical Trials

  2026cites this paper
• The Saudi FDA drug evaluation timeline in comparison with international counterparts: a retrospective observational study

  2026cites this paper
• Integrating GIS and Genomics for AMR One Health Drug Target Discovery in Imipenem-Resistant Escherichia coli

  2026cites this paper
• Examining the impact of e-cigarette advertisement exposure with fruit flavour features among US young adults of varying tobacco-use statuses

  2026cites this paper
• Bridging the knowledge gap: Thai parents’ perspectives on dengue infection and its vaccination and the need for targeted promotion

  2026cites this paper
• Alcohol use‐specific treatment initiation among patients undergoing surgical procedures: A retrospective cohort analysis

  2026cites this paper
• The use of venetoclax in the treatment of acute lymphoblastic leukemia—a systematic review

  2026cites this paper
• Living with adrenoleukodystrophy: adult patient and caregiver perspectives

  2026cites this paper
• Addressing ‘futility’ in psychiatry: a consensus statement

  2026cites this paper
• Leveraging Vet-LIRN AMR data from USA to identify potential drug targets in imipenem-resistant E. coli isolates using interactive GIS dashboards, genomic analysis, subtractive genomics, and druggability assessment

  2025cites this paper
• Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela™)

  2025cites this paper
• SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA

  2025cites this paper
• Treatment of type 2 diabetes mellitus - a current view of the different drug classes and strategies for their use

  2025cites this paper
• High-pressure treatment of the green and orange Dunaliella salina biomass: effect on particle size distribution, small amplitude oscillatory shear rheology, and microstructure

  2025cites this paper
• Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system

  2025cites this paper
• FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS

  2025cites this paper
• Assessment of Objective Response Rate by Investigator vs. Blinded Independent Central Review in Pivotal Trials of Oncology Drugs for Solid Tumor Indications

  2025cites this paper
• Cost-efficiency and expanded access modeling of conversion to biosimilar bevacizumab in metastatic colorectal and non-squamous non-small cell lung cancer in Medicare

  2025cites this paper
• Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024

  2025cites this paper
• Precision Medicine in High-Grade Serous Ovarian Cancer: Targeted Therapies and the Challenge of Chemoresistance

  2025cites this paper
• Self-aggregating long-acting injectable microcrystals

  2025cites this paper
• A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference Product

  2025influential citation
• Antimicrobial resistance in bacteria from pig production chain: a systematic review and meta-analyses focused on the Brazilian context

  2025cites this paper
• The future of in silico trials and digital twins in medicine

  2025cites this paper
• Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study

  2025cites this paper
• Clinical Challenges in the Usage and Shortage of Mercaptopurine in Pediatric Oncology: Case Report

  2025cites this paper
• Evaluation of the mid-term surgical outcomes of vNOTES sacrocolpopexy and vNOTES high uterosacral ligament suspension in pelvic organ prolapse

  2025cites this paper
• Upadacitinib for the treatment of radiographic axial spondyloarthritis — case series and review of the literature

  2025cites this paper
• Qualitative and quantitative determination of SIPI-2011 and its two major metabolites in human plasma.

  2025cites this paper
• Activity of Rezafungin Against Echinocandin Non–wild type Candida glabrata Clinical Isolates From a Global Surveillance Program

  2025influential citation
• Recurrent Medical Device Reporting on Issues Experienced With a Hemodialysis System Leads to Manufacturer Action

  2025cites this paper
• Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients

  2025cites this paper
• Pressurized liquid extraction and GC/MS determination of model contaminants in HDPE - Application to recycling of post-consumer polyolefins using limonene.

  2025cites this paper
• Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities

  2025influential citation
• Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs

  2025cites this paper
• Neonatal skin antisepsis with alcohol-based compared to aqueous 2% chlorhexidine, used in moderate preterm infants or extremely preterm infants after the first week of life, is safe and may be associated with a reduced incidence of catheter-related bloodstream infections

  2025cites this paper
• What is Psychological Support in the Context of Psychedelic Clinical Trials?

  2025cites this paper
• Efficacy of rotavirus vaccines in Indonesia: A review of genotype distribution and impact

  2025cites this paper
• Randomized experimental test of a reduced-exposure message for an e-cigarette: comprehension and related misperceptions

  2025cites this paper
• Past, present, and future perspectives on aztreonam and avibactam

  2025cites this paper
• The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects

  2025cites this paper
• Comprehensive bibliographic study of the framework of complex generic drugs

  2025cites this paper
• Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative Blueprint

  2025cites this paper
• Scoping review of the availability and uptake of disease modifying therapies in children and adolescents with multiple sclerosis

  2025cites this paper
• Comprehension and Use of the Over-the-Counter Hearing Aid Product Information Label

  2025cites this paper
• Twenty years of the four-factor prothrombin complex concentrate Octaplex/Balfaxar: A narrative review.

  2025cites this paper
• Chitosan, derivatives, and its nanoparticles: Preparation, physicochemical properties, biological activities, and biomedical applications - A comprehensive review.

  2025cites this paper
• Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review

  2025cites this paper
• Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance

  2025cites this paper
• Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV

  2025cites this paper
• A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections

  2025cites this paper
• A Review on the Multidisciplinary Approach for Cancer Management in the Eastern Mediterranean Region: A Focus on Nutritional, Lifestyle and Supportive Care

  2025cites this paper
• Food Defense in the Extra Neutral Alcohol Industry: Ensuring Safety Against Intentional Contaminations

  2025cites this paper
• Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?

  2025cites this paper
• COVID-19 Vaccine Uptake Inequality Among Children: A Multidimensional Demographic Analysis

  2025cites this paper
• Administration of Nirsevimab for RSV Prophylaxis in Infants: A Comprehensive Review

  2025cites this paper
• Prediction of Interspecies Translation for Targeting Delivery Coefficients of GalNAc-siRNA Silencing Apolipoprotein C-III Using a Mechanistic Minimal Physiologically Based Pharmacokinetic/Pharmacodynamic Model

  2025influential citation
• The Next-Generation Sequencing Quality Initiative and Challenges in Clinical and Public Health Laboratories

  2025cites this paper
• Evolution of mobility, pain/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient survey

  2025cites this paper
• Beating the Odds: A Successful Pregnancy in a Patient With ALK-Rearranged Lung Cancer on Alectinib

  2025influential citation
• Personal data protection in mHealth apps: international experience and prospects for legislative changes in Ukraine.

  2025cites this paper
• New Serious Safety Warnings for Targeted Anticancer Agents After Their Initial FDA Approval

  2025cites this paper
• Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice

  2025cites this paper
• Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France

  2025cites this paper
• The Design and Cell-Free Protein Synthesis of a Pembrolizumab Single-Chain Variable Fragment

  2025cites this paper
• Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series

  2025cites this paper
• An empirical study on LLM-based classification of requirements-related provisions in food-safety regulations

  2025cites this paper
• Association of statins use and genetic susceptibility with incidence of Alzheimer's disease

  2025cites this paper
• Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol

  2025cites this paper
• Impact of Rule 11 on the European Medical Software Landscape: Analysis of EUDAMED and Further Databases Three Years After MDR Implementation

  2025influential citation
• Second-Generation Antipsychotic–Associated Serious Adverse Events in Women

  2025cites this paper
• Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension

  2025cites this paper
• Evolution in the prescription and cost of non‐intravenous rescue benzodiazepines for the treatment of seizure emergencies

  2025cites this paper
• MicroRNA-based recent research developments in Alzheimer's disease

  2025cites this paper
• Evaluation of Physicochemical, Microstructure Parameters (Q3) and Performance Attributes of Commercial Ketoprofen Gels

  2025influential citation
• A review of human factors and infusion pumps: lessons for procurement

  2025cites this paper
• Laboratory-developed tests and in vitro diagnostics: A regulatory overview for anatomic pathology

  2025cites this paper
• The “TASK” of Breathing: Anesthetic Relevance of Background Two-Pore Domain Potassium Channels as Therapeutic Targets for Respiratory Control

  2025cites this paper
• Prevalence of Shiga-Toxigenic Escherichia coli in Bovine Manure in the Mid-Atlantic Region of the United States

  2025cites this paper
• Pediatric Pharmacoepidemiology and Drug Development From a Regulatory Perspective

  2025cites this paper
• Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age

  2025cites this paper
• Ensuring safety first: GLP‐1RAs in reproductive and endometrial research

  2025cites this paper
• Five years of post-marketing liver safety data from the tolvaptan Risk Evaluation and Mitigation Strategy

  2025cites this paper
• Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database

  2025cites this paper
• Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

  2025cites this paper
• Safety of ilunocitinib tablets (Zenrelia™) after once daily oral administration in dogs

  2025cites this paper
• Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study

  2025cites this paper
• Characterizing the Cellular Constituents of Proximal Airway Disease in Granulomatosis With Polyangiitis

  2025cites this paper
• Evidence-Based Design of Prescription Medication Information: An Updated Scoping Review

  2025cites this paper
• Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post‐marketing surveillance

  2025cites this paper
• Candida auris: A Continuing Threat

  2025cites this paper
• Metabolomics strategy for diagnosing urinary tract infections

  2025cites this paper
• Viral Transmission in Sea Food Systems: Strategies for Control and Emerging Challenges

  2025cites this paper
• Relationship Between Employee Food Safety Training and Food Safety Risk Factors at Fort Liberty Military Installation in North Carolina

  2025cites this paper
• Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta‐analysis of non‐Asian studies

  2025cites this paper
• TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasia

  2025influential citation
• Factors of E-Consumer Behavior for E-Pharmacy Adoption in India: A Literature Review

  2025cites this paper
• Real-World Intravitreal Aflibercept 2 mg Treatment of Macular Oedema Secondary to Retinal Vein Occlusion in Italy: 24-Month Results from the AURIGA Observational Study

  2025cites this paper
• Impact of counterion and salt form on the properties of long-acting injectable peptide hydrogels for drug delivery

  2025cites this paper